← Leaderboards
Sunitha Nagrath
Massachusetts General Hospital
$6,220,172
Attributed
$8,438,301
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2009–25$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,438,301 · 5
By mechanism
R01$5,037,706 · 2
DP2$2,090,257 · 1
R33$1,010,339 · 1
R56$299,999 · 1
Top collaborators
- Theodore S Lawrence4 shared
- Deepak Nagrath4 shared
- Nithya Ramnath3 shared
- Jinsang Kim1 shared
- Max S. Wicha1 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Alice T Shaw$3,731,101
- Jessica Jiyeong Lin$1,690,059
- Daniel A. Haber$29,412,047
- Mehmet Toner$56,861,630
- Shyamala Maheswaran$4,911,288
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsMalignant NeoplasmsTumorRecurrenceNeoplasm Circulating CellsTissuesNeoplasm MetastasisBasePublic Health RelevanceCancer CellPancreatic Ductal AdenocarcinomaMalignant Neoplasm Of PancreasBloodPancreasSamplingTechnologyMicrofluidicsGenomicsPathway InteractionsPrimary NeoplasmComplexCoculture TechniquesMolecular ProfilingCell Separation
Grant awards (15)
Targeting Stromal Influences on BCKA Addiction in PDAC Tumors$574,113
R01 · FY2025 · CA
Targeting Stromal Influences on BCKA Addiction in PDAC Tumors$534,216
R01 · FY2024 · CA
Targeting Stromal Influences on BCKA Addiction in PDAC Tumors$579,715
R01 · FY2023 · CA
Targeting Stromal Influences on BCKA Addiction in PDAC Tumors$581,396
R01 · FY2022 · CA
Label free microfluidic isolation, characterization and ex vivo expansion of CTCs$557,904
R01 · FY2021 · CA · contact PI
Label free microfluidic isolation, characterization and ex vivo expansion of CTCs$557,904
R01 · FY2020 · CA · contact PI
Label free microfluidic isolation, characterization and ex vivo expansion of CTCs$541,166
R01 · FY2019 · CA · contact PI
Label free microfluidic isolation, characterization and ex vivo expansion of CTCs$556,775
R01 · FY2018 · CA · contact PI
High Throughput GO Chip isolation of Lung CTCs for Molecular Diagnosis and Drug Testing$333,698
R33 · FY2018 · CA · contact PI
Label free microfluidic isolation, characterization and ex vivo expansion of CTCs$554,517
R01 · FY2017 · CA · contact PI
High Throughput GO Chip isolation of Lung CTCs for Molecular Diagnosis and Drug Testing$332,977
R33 · FY2017 · CA · contact PI
High Throughput GO Chip isolation of Lung CTCs for Molecular Diagnosis and Drug Testing$343,664
R33 · FY2016 · CA · contact PI
Tunable Polymer-Graphene Oxide Composite for Single Cell Analysis of Breast Cancer CTCs & CSCs$299,999
R56 · FY2016 · CA · contact PI
Engineering sensitive microfluidic multiplex technology for isolating circulating$1,930,771
DP2 · FY2009 · OD · contact PI
Engineering sensitive microfluidic multiplex technology for isolating circulating$159,486
DP2 · FY2009 · OD · contact PI